William Morice II, M.D., Ph.D., highlights data-driven reasons health systems benefit from the lab service line and strategies to bolster performance.

Review the art of delivering clear, constructive feedback; tips for navigating potentially challenging conversations with respect; highlighting the importance of positive feedback.

As drug trends and diagnostic technologies evolve, toxicology must adapt to meet the demands of healthcare, workplace safety, and public health—focusing on opioid detection, CBD use, patient-centered testing, and new methods like saliva analysis, each bringing distinct challenges and opportunities. The following podcast episodes feature chemistry-related interviews that discuss these topics.

Topic highlights include: Mayo Clinic Health System turns 30, Doctors say now is time to get flu shot, White House releases strategy for ending hunger in US by 2030

William Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and CEO and president of Mayo Clinic Laboratories, joins "Answers From the Lab" for his weekly leadership update with host Bobbi Pritt, M.D. In this episode, Dr. Pritt and Dr. Morice cover current trends for monkeypox and COVID-19, their thoughts as autumn begins, getting back to infection prevention basics, and a quick legislation update.

Due to hurricane Ian, Mayo Clinic Laboratories' specimen pickup and delivery schedules will be altered.

In an effort to eliminate interpretation mistakes and in turn improve diagnosis and treatment options for patients who have kidney stones, a team of researchers from Mayo Clinic’s Department of Laboratory Medicine and Pathology recently conducted a 12-month study to determine whether the use of artificial intelligence-trained algorithms can find errors in manually reviewed and reported kidney stone composition results.

This week's research roundup features: Robotics in neurosurgery: current prevalence and future directions

Lisa Brown, quality specialist for Mayo Clinic Laboratories customer service, explains working "behind the scenes" when a client calls Mayo Clinic Laboratories with an inquiry, that call is typically picked up within 20 seconds by an agent from Mayo Laboratory Inquiry (MLI). There are no phone trees or automated menus to wade through before they reach an agent. Agents mind the phones 24/7, 365 days a year.

Topic highlights include: White House launches monkeypox research agenda, Mayo Clinic: collaborations, startups to drive innovation, Why the latest screening tests and treatments offer hope for ovarian cancer

William Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and CEO and president of Mayo Clinic Laboratories, joins "Answers From the Lab" for his weekly leadership update with host Bobbi Pritt, M.D. In this episode, Dr. Pritt and Dr. Morice discuss the Saving Access to Laboratory Services Act (SALSA), how it is designed to mitigate harmful effects of the Protecting Access to Medicare Act (PAMA), where the legislation stands today, and how to get involved in advocacy.

Connie Ohnstad is the supervisor for Mayo Clinic Laboratories Inventory, which includes Mayo Clinic Laboratories Packaging and Specimen Kit Orders (SKO). Connie wears many hats as a supervisor at MCL, and she has a long history with Mayo Clinic, which has employed several generations of Connie’s family. She takes pride in ensuring that every day she offers her best for her employees, patients, and clients.

Katherine Geiersbach, M.D., explains how Mayo Clinic Laboratories' PIK3CA assay informs breast cancer treatment. The assay identifies patients eligible for a certain second-line therapy when initial treatment has failed.

This week's research roundup features: Into the future: a pilot study combining imaging with molecular profiling to predict resectability in ovarian cancer

By collaborating with Mayo Clinic Laboratories, Morris Hospital & Healthcare Center has been able to expand complex and specialized lab testing in the communities they serve.